RESUMEN
BACKGROUND: Electroacupuncture (EA) has been reported to improve intestinal motility in mice with postoperative ileus (POI). Previous studies, however, have yielded heterogeneous results regarding the effect of EA on POI. METHODS: Herein, a POI mouse model was constructed by intestinal manipulation. To evaluate the effect of EA treatment on colonic transit, the levels of inflammatory markers (macrophage inflammatory protein (MIP)-1α, interleukin (IL)-1ß, IL-6, monocyte chemotactic protein (MCP)-1 and intercellular adhesion molecule (ICAM)-1) were detected by enzyme-linked immunosorbent assay (ELISA); immune cell infiltration was detected by immunohistochemical staining of myeloperoxidase (MPO), ectodysplasin (ED)-1 and ED-2, and the percentage of CD4+ interferon (IFN)-γ+ Th1 cells and IFN-γ secretion levels were determined. Activated Th1 cells and pentoxifylline, a cell differentiation inhibitor, were used to assess the role of Th1 cells in EA treatment of POI. Neostigmine administration and unilateral vagotomy were performed to confirm whether the effects of EA treatment on Th1 cells were mediated by the vagus nerve (VN). RESULTS: The results revealed that EA treatment at ST36 improved POI, as indicated by a decreased level of inflammatory-related markers and immune cell infiltration and shortened colonic transit time. The activated Th1 cells abolished the effects of EA treatment on POI. The effects of EA treatment on POI were enhanced by stimulation of the VN along with a decreased level of Th1 cells, but these effects were abolished by vagotomy along with an increased percentage of Th1 cells; this result indicates that the VN mediates the role of Th1 cells in the effects of EA treatment of POI. CONCLUSION: Our findings showed that the effects of EA treatment of POI were mainly mediated by Th1 cells through the stimulation of the VN and inhibition of the inflammatory response.
Asunto(s)
Electroacupuntura , Ileus , Complicaciones Posoperatorias , Células TH1 , Nervio Vago , Animales , Células TH1/inmunología , Ratones , Ileus/terapia , Ileus/inmunología , Nervio Vago/inmunología , Masculino , Humanos , Complicaciones Posoperatorias/terapia , Complicaciones Posoperatorias/inmunología , Ratones Endogámicos C57BL , Modelos Animales de Enfermedad , Interferón gamma/metabolismo , Interferón gamma/inmunología , Interleucina-6/metabolismo , Interleucina-6/inmunología , Molécula 1 de Adhesión Intercelular/metabolismo , Molécula 1 de Adhesión Intercelular/genética , Interleucina-1beta/metabolismo , Inflamación/terapiaRESUMEN
The cholinergic anti-inflammatory pathway (CAP) is a classic neuroimmune pathway, consisting of the vagus nerve, acetylcholine (ACh)-the pivotal neurotransmitter of the vagus nerve-and its receptors. This pathway can activate and regulate the activities of immune cells, inhibit cell proliferation and differentiation, as well as suppress cytokine release, thereby playing an anti-inflammatory role, and widely involved in the occurrence and development of various diseases; recent studies have demonstrated that the CAP may be a new target for the treatment of autoimmune rheumatic diseases. In this review, we will summarize the latest progress with the view of figuring out the role of the cholinergic pathway and how it interacts with inflammatory reactions in several autoimmune rheumatic diseases, and many advances are results from a wide range of experiments performed in vitro and in vivo.
Asunto(s)
Enfermedades Autoinmunes/etiología , Enfermedades Reumáticas/etiología , Acetilcolina/inmunología , Animales , Artritis Reumatoide/etiología , Artritis Reumatoide/inmunología , Enfermedades Autoinmunes/inmunología , Humanos , Inflamación/inmunología , Lupus Eritematoso Sistémico/etiología , Lupus Eritematoso Sistémico/inmunología , Neuroinmunomodulación , Osteoartritis/etiología , Osteoartritis/inmunología , Receptores Colinérgicos/inmunología , Enfermedades Reumáticas/inmunología , Esclerodermia Sistémica/etiología , Esclerodermia Sistémica/inmunología , Síndrome de Sjögren/etiología , Síndrome de Sjögren/inmunología , Espondiloartropatías/etiología , Espondiloartropatías/inmunología , Nervio Vago/inmunologíaRESUMEN
Neuromodulation of immune function by stimulating the autonomic connections to the spleen has been demonstrated in rodent models. Consequently, neuroimmune modulation has been proposed as a new therapeutic strategy for the treatment of inflammatory conditions. However, demonstration of the translation of these immunomodulatory mechanisms in anatomically and physiologically relevant models is still lacking. Additionally, translational models are required to identify stimulation parameters that can be transferred to clinical applications of bioelectronic medicines. Here, we performed neuroanatomical and functional comparison of the mouse, rat, pig, and human splenic nerve using in vivo and ex vivo preparations. The pig was identified as a more suitable model of the human splenic innervation. Using functional electrophysiology, we developed a clinically relevant marker of splenic nerve engagement through stimulation-dependent reversible reduction in local blood flow. Translation of immunomodulatory mechanisms were then assessed using pig splenocytes and two models of acute inflammation in anesthetized pigs. The pig splenic nerve was shown to locally release noradrenaline upon stimulation, which was able to modulate cytokine production by pig splenocytes. Splenic nerve stimulation was found to promote cardiovascular protection as well as cytokine modulation in a high- and a low-dose lipopolysaccharide model, respectively. Importantly, splenic nerve-induced cytokine modulation was reproduced by stimulating the efferent trunk of the cervical vagus nerve. This work demonstrates that immune responses can be modulated by stimulation of spleen-targeted autonomic nerves in translational species and identifies splenic nerve stimulation parameters and biomarkers that are directly applicable to humans due to anatomical and electrophysiological similarities.
Asunto(s)
Sistema Inmunológico/inervación , Inmunomodulación/efectos de los fármacos , Bazo/inmunología , Sistema Nervioso Simpático/inmunología , Nervio Vago/inmunología , Animales , Femenino , Expresión Génica , Humanos , Sistema Inmunológico/efectos de los fármacos , Inflamación , Interleucina-6/genética , Interleucina-6/inmunología , Lipopolisacáridos/farmacología , Ratones , Microcirculación/efectos de los fármacos , Microcirculación/genética , Microcirculación/inmunología , Norepinefrina/farmacología , Ratas , Especificidad de la Especie , Bazo/efectos de los fármacos , Bazo/inervación , Bazo/patología , Porcinos , Sistema Nervioso Simpático/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunología , Nervio Vago/efectos de los fármacos , Estimulación del Nervio Vago/métodosRESUMEN
Influenza A virus (IAV) is rapidly detected in the airways by the immune system, with resident parenchymal cells and leukocytes orchestrating viral sensing and the induction of antiviral inflammatory responses. The airways are innervated by heterogeneous populations of vagal sensory neurons which also play an important role in pulmonary defense. How these neurons respond to IAV respiratory infection remains unclear. Here, we use a murine model to provide the first evidence that vagal sensory neurons undergo significant transcriptional changes following a respiratory IAV infection. RNA sequencing on vagal sensory ganglia showed that IAV infection induced the expression of many genes associated with an antiviral and pro-inflammatory response and this was accompanied by a significant increase in inflammatory cell recruitment into the vagal ganglia. Assessment of gene expression in single-vagal sensory neurons confirmed that IAV infection induced a neuronal inflammatory phenotype, which was most prominent in bronchopulmonary neurons, and also evident in some neurons innervating other organs. The altered transcriptome could be mimicked by intranasal treatment with cytokines and the lung homogenates of infected mice, in the absence of infectious virus. These data argue that IAV pulmonary infection and subsequent inflammation induces vagal sensory ganglia neuroinflammation and this may have important implications for IAV-induced morbidity.
Asunto(s)
Inflamación/inmunología , Virus de la Influenza A , Pulmón/inervación , Infecciones por Orthomyxoviridae/inmunología , Células Receptoras Sensoriales/inmunología , Nervio Vago/inmunología , Animales , Femenino , Pulmón/virología , Masculino , Ratones , Ratones Endogámicos C57BL , Células Receptoras Sensoriales/metabolismo , Transcripción Genética , Nervio Vago/metabolismoRESUMEN
Obesity and the metabolic syndrome (MetS), which have reached pandemic proportions significantly increase the risk for type 2 diabetes, cardiovascular disease, and other serious conditions. Recent data with COVID-19 patients indicate that obesity also is a significant risk factor for this novel viral disease and poor outcome of associated critical illness. These findings considerably change the view of obesity as a driver of serious, but slowly-progressing chronic diseases, and emphasize the urgency to explore new therapeutic approaches. Inflammation is a recognized driver of metabolic derangements in obesity and MetS, and a core feature of COVID-19 pathobiology. Recent advances in our understanding of inflammatory regulation have highlighted the role of the nervous system and the vagus nerve-based inflammatory reflex. Current bioelectronic and pharmacological therapeutic explorations centered on the inflammatory reflex offer new approaches for conditions characterized by immune and metabolic dysregulation and for ameliorating the escalating burden of obesity, MetS, and COVID-19.
Asunto(s)
COVID-19 , Inflamación , Obesidad , Nervio Vago/inmunología , COVID-19/inmunología , COVID-19/metabolismo , Humanos , Inflamación/inmunología , Inflamación/metabolismo , Síndrome Metabólico/inmunología , Obesidad/epidemiología , Obesidad/inmunología , Obesidad/terapia , SARS-CoV-2RESUMEN
Abnormalities in CD4+ T cell (Th cell) differentiation play an important role in the pathogenesis of viral myocarditis (VMC). Our previous studies demonstrated that activation of the cholinergic anti-inflammatory pathway (CAP) alleviated the inflammatory response. In addition, we observed that right cervical vagotomy aggravates VMC by inhibiting CAP. However, the vagus nerve's effect on differentiation of CD4+ T cells has not been studied in VMC mice to date. In this study, we investigated the effects of cervical vagotomy and the α7nAChR agonist pnu282987 on CD4+ T cell differentiation in a murine myocarditis model (BALB/c) infected with coxsackievirus B3 (CVB3). Splenic CD4+ T cells from CVB3-induced mice obtained and cultured to investigate the potential mechanism of CD4+ T cell differentiation. Each Th cell subset was analyzed by flow cytometry. Our results showed that right cervical vagotomy increased proportions of Th1 and Th17 cells and decreased proportions of Th2 and Treg cells in the spleen. Vagotomy-induced upregulation of T-bet, Ror-γ, IFN-γ, and IL-17 expression while downregulating the expression of Gata3, Foxp3, and IL-4 in the heart. In addition, we observed upregulated levels of proinflammatory cytokines, aggravated myocardial lesions and cellular infiltration, and worsened cardiac function in VMC mice. Pnu282987 administration reversed these outcomes. Furthermore, vagotomy inhibited JAK2-STAT3 activation and enhanced NF-κB activation in splenic CD4+ T cells. The CD4+ T cell differentiation was related to JAK2-STAT3 and NF-κB signal pathways. In conclusion, vagus nerve modulates the inflammatory response by regulating CD4+ T cell differentiation in response to VMC.
Asunto(s)
Linfocitos T CD4-Positivos/fisiología , Diferenciación Celular/inmunología , Infecciones por Coxsackievirus/inmunología , Enterovirus Humano B/inmunología , Miocarditis/inmunología , Miocarditis/virología , Nervio Vago/inmunología , Enfermedad Aguda , Animales , Linfocitos T CD4-Positivos/inmunología , Citocinas/inmunología , Enterovirus Humano B/clasificación , Masculino , Ratones , Ratones Endogámicos BALB CRESUMEN
Anorexia nervosa represents a severe mental disorder associated with food avoidance and malnutrition. In patients suffering from anorexia nervosa, cardiovascular complications are the main reason leading to morbidity and mortality. However, the origin and pathological mechanisms leading to higher cardiovascular risk in anorexia nervosa are still unclear. In this aspect, the issue of exact pathological mechanisms as well as sensitive biomarkers for detection of anorexia nervosa-linked cardiovascular risk are discussed. Therefore, this review synthesised recent evidence of dysfunction in multiple neuroendocrine axes and alterations in the immune system that may represent anorexia nervosa-linked pathological mechanisms contributing to complex cardiovascular dysregulation. Further, this review is focused on identification of non-invasive biomarkers for the assessment of increased cardiovascular risk in anorexia nervosa that can be linked to a clinical application. Complex non-invasive assessment of cardiovascular autonomic regulation-cardiac vagal control (heart rate variability), sympathetic vascular activity (blood pressure variability), and cardiovascular reflex control (baroreflex sensitivity)-could represent a promising tool for early diagnosis, personalized therapy, and monitoring of therapeutic interventions in anorexia nervosa particularly at a vulnerable adolescent age.
Asunto(s)
Anorexia Nerviosa/fisiopatología , Sistema Nervioso Autónomo/fisiopatología , Enfermedades Cardiovasculares/fisiopatología , Sistemas Neurosecretores/fisiopatología , Adolescente , Anorexia Nerviosa/complicaciones , Anorexia Nerviosa/inmunología , Presión Sanguínea , Enfermedades Cardiovasculares/complicaciones , Enfermedades Cardiovasculares/inmunología , Femenino , Frecuencia Cardíaca , Humanos , Sistema Inmunológico/fisiopatología , Nervio Vago/inmunología , Nervio Vago/fisiopatologíaRESUMEN
The outbreak of coronavirus disease 2019 (COVID-19) underlined the urgent need for alleviating cytokine storm. We propose here that activating the cholinergic anti-inflammatory pathway (CAP) is a potential therapeutic strategy. However, there is currently no approved drugs targeting the regulatory pathway. It is evident that nicotine, anisodamine and some herb medicine, activate the CAP and exert anti-inflammation action in vitro and in vivo. As the vagus nerve affects both inflammation and specific immune response, we propose that vagus nerve stimulation by invasive or non-invasive devices and acupuncture at ST36, PC6, or GV20, are also feasible approaches to activate the CAP and control COVID-19. It is worth to investigate the efficacy and safety of the strategy in patients with COVID-19.
Asunto(s)
COVID-19/terapia , Síndrome de Liberación de Citoquinas/terapia , Neuroinmunomodulación/inmunología , Estimulación del Nervio Vago/métodos , Nervio Vago/inmunología , Acupuntura , Antiinflamatorios/farmacología , Citocinas/sangre , Medicamentos Herbarios Chinos/farmacología , Humanos , Inflamación/terapia , Nicotina/farmacología , SARS-CoV-2 , Alcaloides Solanáceos/farmacologíaRESUMEN
Bioelectronic medicine is an evolving field in which new insights into the regulatory role of the nervous system and new developments in bioelectronic technology result in novel approaches in disease diagnosis and treatment. Studies on the immunoregulatory function of the vagus nerve and the inflammatory reflex have a specific place in bioelectronic medicine. These studies recently led to clinical trials with bioelectronic vagus nerve stimulation in inflammatory diseases and other conditions. Here, we outline key findings from this preclinical and clinical research. We also point to other aspects and pillars of interdisciplinary research and technological developments in bioelectronic medicine.
Asunto(s)
Inflamación/fisiopatología , Inflamación/terapia , Investigación Biomédica Traslacional , Nervio Vago/fisiología , Animales , Enfermedades Autoinmunes/fisiopatología , Enfermedades Autoinmunes/terapia , Modelos Animales de Enfermedad , Humanos , Neuroinmunomodulación , Reflejo , Nervio Vago/anatomía & histología , Nervio Vago/inmunologíaRESUMEN
The autonomic nervous system innervates all lymphoid tissues including the spleen therefore providing a link between the central nervous system and the immune system. The only known mechanism of neural inhibition of inflammation in the spleen relies on the production of norepinephrine by splenic catecholaminergic fibers which binds to ß2-adrenergic receptors (ß 2-ARs) of CD4+ T cells. These CD4+ T cells trigger the release of acetylcholine that inhibits the secretion of inflammatory cytokines by macrophages through α7 nicotinic acetylcholine receptor (α7nAchRs) signaling. While the vagal anti-inflammatory pathway has been extensively studied in rodents, it remains to be determined whether it coexists with other neural pathways. Here, we have found that three nerve branches project to the spleen in mice. While two of these nerves are associated with an artery and contain catecholaminergic fibers, the third is located at the apex of the spleen and contain both catecholaminergic and cholinergic fibers. We found that electrical stimulation of the apical nerve, but not the arterial nerves, inhibited inflammation independently of lymphocytes. In striking contrast to the anti-inflammatory pathway mechanism described so far, we also found that the inhibition of inflammation by apical nerve electrical stimulation relied on signaling by both ß 2-ARs and α7nAchRs in myeloid cells, with these two signaling pathways acting in parallel. Most importantly, apical splenic nerve electrical stimulation mitigated clinical symptoms in a mouse model of rheumatoid arthritis further providing the proof-of-concept that such an approach could be beneficial in patients with Immune-mediated inflammatory diseases.
Asunto(s)
Células Mieloides/inmunología , Receptores Adrenérgicos/inmunología , Receptores Nicotínicos/inmunología , Bazo/inmunología , Bazo/inervación , Acetilcolina/metabolismo , Animales , Estimulación Eléctrica , Femenino , Ratones Endogámicos C57BL , Ratones Transgénicos , Norepinefrina/metabolismo , Bazo/fisiopatología , Factor de Necrosis Tumoral alfa/inmunología , Nervio Vago/inmunología , Estimulación del Nervio VagoRESUMEN
Depression or stress is reportedly related to the overflow of inflammatory factors in the body and T cells were reported to play important roles in balancing the release of inflammatory factors through vagus nerve circuit. However, few works have been conducted to find if natural killer (NK) cells can also exert the similar function in the reported vagus nerve circuit as T cells and if there was any relationship between depression and this function. In the present study, the behavioral tests on BALB/c mice indicated that the depressant-like symptoms could be improved and simultaneously the concentrations of inflammatory factors in peripheral blood could be reduced significantly by adoptively transferring NK cells into stressed BALB/c mice. The results revealed that NK cells could control the release of inflammatory factors secreted by macrophages and ß2-AR (ß2-adrenergic receptor) on the NK cells were of great importance. Behavioral tests on NCG mice indicated that the antidepressant-like effects of NK cells notably declined after adoptively transferring NK cells with ß2-AR deficiency or with ChAT (choline acetyltransferase) deficiency into stressed NCG mice. Simultaneously, the anti-inflammatory effects also declined significantly both in vivo and in vitro, which indicated that the antidepressant-like property of NK cells may be related to its ability of controlling the release of inflammatory factors. Taken together, we find that NK cells may balance the release of inflammatory factors in our body by transporting the information between the terminal vagal branches and macrophages, which is the mechanism that NK cells may exert antidepressant-like effects.
Asunto(s)
Antidepresivos/inmunología , Citocinas/metabolismo , Inflamación/inmunología , Células Asesinas Naturales/inmunología , Animales , Antidepresivos/metabolismo , Conducta Animal , Colina O-Acetiltransferasa/metabolismo , Repeticiones Palindrómicas Cortas Agrupadas y Regularmente Espaciadas , Citocinas/farmacocinética , Inflamación/patología , Células Asesinas Naturales/patología , Macrófagos/inmunología , Masculino , Ratones , Ratones Endogámicos BALB C , Receptores Adrenérgicos beta 2/metabolismo , Estrés Psicológico/tratamiento farmacológico , Nervio Vago/inmunologíaRESUMEN
Recent studies have shown renal protective effects of bioelectric approaches, including ultrasound treatment, electrical vagus nerve stimulation, and optogenetic brainstem C1 neuron stimulation. The renal protection acquired by all three modalities was lost in splenectomized mice and/or α7 subunit of the nicotinic acetylcholine receptor-deficient mice. C1 neuron-mediated renal protection was blocked by ß2-adrenergic receptor antagonist. These findings indicate that all three methods commonly, at least partially, activate the cholinergic anti-inflammatory pathway, a well-studied neuroimmune pathway. In this article, we summarize the current understanding of neuroimmune axis-mediated kidney protection in preclinical models of acute kidney injury by these three modalities. Examination of the differences among these three modalities might lead to a further elucidation of the neuroimmune axis involved in renal protection and is of interest for developing new therapeutic approaches.
Asunto(s)
Lesión Renal Aguda/patología , Neuroinmunomodulación/inmunología , Lesión Renal Aguda/inmunología , Animales , Sistema Nervioso Autónomo/inmunología , Sistema Nervioso Autónomo/fisiopatología , Humanos , Inflamación/patología , Ratones , Nervio Vago/inmunología , Nervio Vago/fisiopatologíaRESUMEN
John Cryan talks about the research that exploring mechanisms of how gut bacteria could influence our brain and behavior.
Asunto(s)
Microbioma Gastrointestinal , Nervio Vago/inmunologíaRESUMEN
Accumulating evidence points to a beneficial effect ofvagus nerve activity in tumor development. The vagus nerve is proposed to slow tumorigenesis because of its anti-inflammatory properties mediated through ACh and the α7nAChR. Since α7nAChRs are widely expressed by many types of immune cells we hypothesized that the vagus nerve affects the tumor microenvironment and anticancer immunity. We found direct evidence in studies using animal cancer models that vagus nerve stimulation alters immunological responses relevant to the tumor microenvironment. Also studies in pathologies other than cancer suggest a role for the vagus nerve in altering immunological responses relevant to anticancer immunity. These results provide a rationale to expect that vagus nerve stimulation, in combination with conventional cancer treatments, may improve the prognosis of cancer patients by promoting anticancer immunity.
Asunto(s)
Neoplasias/inmunología , Neoplasias/terapia , Nervio Vago/inmunología , Animales , Antineoplásicos/inmunología , Antineoplásicos/uso terapéutico , Humanos , Microambiente Tumoral/inmunología , Estimulación del Nervio Vago/métodos , Receptor Nicotínico de Acetilcolina alfa 7/inmunologíaRESUMEN
Improved understanding of neuroimmune communication and the neural regulation of immunity and inflammation has recently led to proposing the concept of the "neuroimmune communicatome." This advance is based on experimental evidence for an organized and brain-integrated reflex-like relationship and dialogue between the nervous and the immune systems. A key circuitry in this communicatome is provided by efferent vagus nerve fibers and cholinergic signaling. Inflammation and metabolic alterations coexist in many disorders affecting the liver and the gastrointestinal (GI) tract, including obesity, metabolic syndrome, fatty liver disease, liver injury, and liver failure, as well as inflammatory bowel disease. Here, we outline mechanistic insights regarding the role of the vagus nerve and cholinergic signaling in the regulation of inflammation linked to metabolic derangements and the pathogenesis of these disorders in preclinical settings. Recent clinical advances using this knowledge in novel therapeutic neuromodulatory approaches within the field of bioelectronic medicine are also briefly summarized.
Asunto(s)
Neuronas Colinérgicas/fisiología , Tracto Gastrointestinal/fisiología , Hígado/fisiología , Neuroinmunomodulación , Nervio Vago/fisiología , Animales , Tracto Gastrointestinal/inmunología , Humanos , Hígado/inmunología , Nervio Vago/inmunologíaRESUMEN
Electrical stimulation of the vagus nerve (VNS) is a novel strategy used to treat inflammatory conditions. Therapeutic VNS activates both efferent and afferent fibers; however, the effects attributable to vagal afferent stimulation are unclear. Here, we tested if selective activation of afferent fibers in the abdominal vagus suppresses systemic inflammation. In urethane-anesthetized rats challenged with lipopolysaccharide (LPS, 60⯵g/kg, i.v.), abdominal afferent VNS (2 Hz for 20â¯min) reduced plasma tumor necrosis factor alpha (TNF) levels 90â¯min later by 88% compared with unmanipulated animals. Pre-cutting the cervical vagi blocked this anti-inflammatory action. Interestingly, the surgical procedure to expose and prepare the abdominal vagus for afferent stimulation ('vagal manipulation') also had an anti-inflammatory action. Levels of the anti-inflammatory cytokine IL-10 were inversely related to those of TNF. Prior bilateral section of the splanchnic sympathetic nerves reversed the anti-inflammatory actions of afferent VNS and vagal manipulation. Sympathetic efferent activity in the splanchnic nerve was shown to respond reflexly to abdominal vagal afferent stimulation. These data demonstrate that experimentally activating abdominal vagal afferent fibers suppresses systemic inflammation, and that the efferent neural pathway for this action is in the splanchnic sympathetic nerves.
Asunto(s)
Inflamación/metabolismo , Nervios Esplácnicos/fisiología , Nervio Vago/fisiología , Abdomen/inervación , Vías Aferentes/metabolismo , Vías Aferentes/fisiología , Animales , Antiinflamatorios/farmacología , Citocinas , Modelos Animales de Enfermedad , Inflamación/inmunología , Interleucina-10/análisis , Interleucina-10/sangre , Lipopolisacáridos/farmacología , Masculino , Vías Nerviosas , Ratas , Ratas Sprague-Dawley , Nervios Esplácnicos/inmunología , Sistema Nervioso Simpático , Factor de Necrosis Tumoral alfa/análisis , Factor de Necrosis Tumoral alfa/sangre , Nervio Vago/inmunología , Estimulación del Nervio Vago/métodosRESUMEN
Vernet syndrome is a unilateral palsy of glossopharyngeal, vagus, and accessory nerves. Varicella zoster virus (VZV) infection has rarely been described as a possible cause. A 76-year-old man presented with 1-week-long symptoms of dysphonia, dysphagia, and weakness of the right shoulder elevation, accompanied by a mild right temporal parietal headache with radiation to the ipsilateral ear. Physical examination showed signs compatible with a right XI, X, and XI cranial nerves involvement and also several vesicular lesions in the right ear's concha. He had a personal history of poliomyelitis and chickenpox. Laringoscopy demonstrated right vocal cord palsy. Brain MRI showed thickening and enhancement of right lower cranial nerves and an enhancing nodular lesion in the ipsilateral jugular foramen, in T1 weighted images with gadolinium. Cerebrospinal fluid (CSF) analysis disclosed a mild lymphocytic pleocytosis and absence of VZV-DNA by PCR analysis. Serum VZV IgM and IgG antibodies were positive. The patient had a noticeable clinical improvement after initiation of acyclovir and prednisolone therapy. The presentation of a VZV infection with isolated IX, X, and XI cranial nerves palsy is extremely rare. In our case, the diagnosis of Vernet syndrome as a result of VZV infection was made essentially from clinical findings and supported by analytical and imaging data.
Asunto(s)
Encéfalo/virología , Enfermedades de los Nervios Craneales/virología , Herpesvirus Humano 3/inmunología , Infección por el Virus de la Varicela-Zóster/virología , Parálisis de los Pliegues Vocales/virología , Nervio Accesorio/diagnóstico por imagen , Nervio Accesorio/inmunología , Nervio Accesorio/fisiopatología , Nervio Accesorio/virología , Anciano , Encéfalo/diagnóstico por imagen , Encéfalo/inmunología , Encéfalo/fisiopatología , Enfermedades de los Nervios Craneales/diagnóstico por imagen , Enfermedades de los Nervios Craneales/inmunología , Enfermedades de los Nervios Craneales/fisiopatología , Nervio Glosofaríngeo/diagnóstico por imagen , Nervio Glosofaríngeo/inmunología , Nervio Glosofaríngeo/fisiopatología , Nervio Glosofaríngeo/virología , Herpesvirus Humano 3/aislamiento & purificación , Humanos , Imagen por Resonancia Magnética , Masculino , Nervio Vago/diagnóstico por imagen , Nervio Vago/inmunología , Nervio Vago/fisiopatología , Nervio Vago/virología , Infección por el Virus de la Varicela-Zóster/diagnóstico por imagen , Infección por el Virus de la Varicela-Zóster/inmunología , Infección por el Virus de la Varicela-Zóster/fisiopatología , Parálisis de los Pliegues Vocales/diagnóstico por imagen , Parálisis de los Pliegues Vocales/inmunología , Parálisis de los Pliegues Vocales/fisiopatologíaRESUMEN
The autonomic nervous system is a powerful regulator of circulatory adjustments to acute hemodynamic stresses. Here we focus on new concepts that emphasize the chronic influence of the sympathetic and parasympathetic systems on cardiovascular pathology. The autonomic neurohumoral system can dramatically influence morbidity and mortality from cardiovascular disease through newly discovered influences on the innate and adaptive immune systems. Specifically, the end-organ damage in heart failure or hypertension may be worsened or alleviated by pro- or anti-inflammatory pathways of the immune system, respectively, that are activated through neurohumoral transmitters. These concepts provide a major new perspective on potentially life-saving therapeutic interventions in the deadliest of diseases.